Logo Comprehensive Cancer Center Niedersachsen
CCC-N > About us > Principal Investigators > Wirth

PD Dr. Thomas Wirth

Thomas Wirth is a Principal Investigator in SP12 and one of two equity officers of the RTG 2978.
 

His research focus lies on cancer immunotherapy, T-Cell vaccines, preclinical cancer models, and T-Cell immunology in infectious disease.
 

Dr. Wirth was member of the Scientific Committee of the UEG from 2017 to 2021 and since 2019 has been a mentor of the Hannover Biomedical Research School (HBRS) for Molecular Medicine.

Curriculum Vitae

Year Position
2015 Board Certification Internal Medicine and Gastroenterology
2015 Habilitation and Venia legendi in Experimental Gastroenterology
2012 Dr. med. (“summa cum laude”), supervisor: Prof. Dr. med. Stefan Kubicka, Medical School Hannover
Since 2010 Research group leader, Department of Gastroenterology, Hepatology and Endocrinology, MHH
2006-2009 Postdoctoral Fellow, Laboratory of John Harty, Department of Microbiology, University of Iowa, Iowa City, US
2005 Full “Approbation” as Physician
2005 MD Thesis ("A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer", summa cum laude)
1999-2004 MD PhD Thesis, supervisor: Prof. Dr. med. Stefan Kubicka, Department of Gastroenterology, Hepatology and Endocrinology, MHH
1997-2004 Studies of Human Medicine, University of Greifswald and Hannover Medical School